Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biophytis SA (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BPTS
Nasdaq
8731
https://www.biophytis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biophytis SA (ADR)
Biophytis Announces Transfer of ADSs to OTC Market
- Apr 24th, 2024 9:30 pm
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program
- Apr 19th, 2024 5:20 am
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
- Apr 18th, 2024 5:20 am
Why Is Penny Stock Biophytis Trading Higher On Tuesday?
- Apr 9th, 2024 4:06 pm
Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up
- Apr 9th, 2024 11:02 am
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities
- Apr 8th, 2024 10:10 pm
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
- Apr 8th, 2024 9:30 pm
Results of the Combined General Meeting on April 2, 2024
- Apr 4th, 2024 9:20 pm
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia
- Mar 22nd, 2024 6:20 am
40 Cities with the Lowest Life Expectancy in the US
- Jan 11th, 2024 6:11 pm
Biophytis Announces Receipt of Nasdaq Notice
- Nov 17th, 2023 10:15 pm
Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazil
- Oct 30th, 2023 5:20 am
Biophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings Panel
- Oct 27th, 2023 9:15 pm
Biophytis Releases Its Half-Yearly Accounts as of 30 June 2023 and Provides an Update on Its Operations
- Sep 27th, 2023 9:45 pm
Biophytis (BPTS) Soars 73% on Partnership With Skyepharma
- Sep 26th, 2023 11:32 am
Biophytis shares surge 73% following partnership deal with Skyepharma
- Sep 25th, 2023 4:09 pm
Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
- Sep 25th, 2023 5:30 am
Biophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19
- Sep 19th, 2023 5:40 am
Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
- Sep 14th, 2023 5:30 am
Biophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in Sarcopenia
- Sep 11th, 2023 5:20 am
Scroll